NeoGenomics Inc (NEO)
14.03
-0.13
(-0.92%)
USD |
NASDAQ |
Apr 24, 16:00
14.03
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Revenue (TTM): 591.64M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 591.64M |
| September 30, 2023 | 574.80M |
| June 30, 2023 | 551.62M |
| March 31, 2023 | 529.78M |
| December 31, 2022 | 509.73M |
| September 30, 2022 | 496.76M |
| June 30, 2022 | 489.31M |
| March 31, 2022 | 485.96M |
| December 31, 2021 | 484.33M |
| September 30, 2021 | 484.59M |
| June 30, 2021 | 488.70M |
| March 31, 2021 | 453.95M |
| December 31, 2020 | 444.45M |
| September 30, 2020 | 425.32M |
| June 30, 2020 | 404.55M |
| March 31, 2020 | 419.28M |
| December 31, 2019 | 408.83M |
| September 30, 2019 | 378.44M |
| June 30, 2019 | 342.86M |
| March 31, 2019 | 308.89M |
| December 31, 2018 | 276.74M |
| September 30, 2018 | 261.69M |
| June 30, 2018 | 251.73M |
| March 31, 2018 | 246.24M |
| December 31, 2017 | 240.25M |
| Date | Value |
|---|---|
| September 30, 2017 | 227.04M |
| June 30, 2017 | 228.67M |
| March 31, 2017 | 229.53M |
| December 31, 2016 | 231.81M |
| September 30, 2016 | 210.87M |
| June 30, 2016 | 175.24M |
| March 31, 2016 | 136.48M |
| December 31, 2015 | 99.80M |
| September 30, 2015 | 97.52M |
| June 30, 2015 | 95.61M |
| March 31, 2015 | 91.91M |
| December 31, 2014 | 87.07M |
| September 30, 2014 | 80.39M |
| June 30, 2014 | 74.06M |
| March 31, 2014 | 68.99M |
| December 31, 2013 | 66.47M |
| September 30, 2013 | 63.04M |
| June 30, 2013 | 60.36M |
| March 31, 2013 | 60.36M |
| December 31, 2012 | 59.87M |
| September 30, 2012 | 57.87M |
| June 30, 2012 | 54.98M |
| March 31, 2012 | 49.84M |
| December 31, 2011 | 43.48M |
| September 30, 2011 | 39.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
342.86M
Minimum
Jun 2019
591.64M
Maximum
Dec 2023
471.84M
Average
484.59M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Teladoc Health Inc | 2.602B |
| Abbott Laboratories | 40.33B |
| Halozyme Therapeutics Inc | 829.25M |
| Verastem Inc | -- |
| Ocugen Inc | -- |